NAXS Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

NAXS heeft een totaal eigen vermogen van SEK844.1M en een totale schuld van SEK0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk SEK847.5M en SEK3.3M.

Belangrijke informatie

Verhouding schuld/eigen vermogen

SEK 0

Schuld

Rente dekkingsratio	n/a
Contant	SEK 186.95m
Aandelen	SEK 844.13m
Totaal verplichtingen	SEK 3.35m
Totaal activa	SEK 847.48m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

NAXS (STO:NAXS) Has Announced That It Will Be Increasing Its Dividend To SEK4.25

Feb 26

If You Like EPS Growth Then Check Out NAXS (STO:NAXS) Before It's Too Late

May 03

How Is NAXS' (STO:NAXS) CEO Compensated?

Feb 28

NAXS AB (publ) (STO:NAXS) Investors Should Think About This Before Buying It For Its Dividend

Feb 01

Shareholders Of NAXS (STO:NAXS) Have Received 9.9% On Their Investment

Dec 04

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( SEK189.9M ) NAXS } overtreffen de korte termijn passiva ( SEK3.3M ).

Langlopende schulden: NAXS heeft geen langlopende schulden.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: NAXS is schuldenvrij.

Schuld verminderen: NAXS heeft de afgelopen 5 jaar geen schulden gehad.

Schuldendekking: NAXS heeft geen schulden en hoeft daarom niet gedekt te worden door de operationele kasstroom.

Rentedekking: NAXS heeft geen schulden, dus de dekking van rentebetalingen is geen probleem.

NAXS Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

NAXS AB (publ) to Report Q1, 2025 Results on Apr 29, 2025

NAXS AB (Publ) Announces CEO Changes

Naxs AB (Publ) Announces Board Changes

Upcoming dividend of kr4.25 per share

NAXS (STO:NAXS) Has Announced That It Will Be Increasing Its Dividend To SEK4.25

Dividend increased to kr4.25

Naxs AB (Publ) Proposes Dividend for the Fiscal Year 2023

Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S (CPSE:CHR).

Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S (CPSE:CHR).

NAXS AB (publ) to Report Fiscal Year 2024 Results on Jan 30, 2025

Upcoming dividend of kr3.75 per share at 5.6% yield

Naxs AB (Publ) Proposes Dividend for the Financial Year 2022

High number of new and inexperienced directors

NAXS AB (publ) to Report Q3, 2023 Results on Oct 26, 2023

NAXS AB (publ) Appoints Gösta Lundgren as Interim CEO

High number of new and inexperienced directors

NAXS AB (publ) Approves Dividend for Financial Year 2021

Upcoming dividend of kr3.50 per share

NAXS AB (publ), Annual General Meeting, Mar 30, 2022

NAXS AB (publ) to Report Fiscal Year 2022 Final Results on Jan 31, 2023

NAXS AB (publ) to Report Fiscal Year 2022 Final Results on Jan 31, 2023

If You Like EPS Growth Then Check Out NAXS (STO:NAXS) Before It's Too Late

NAXS AB (publ) Announces Appointments to Nomination Committee

Upcoming Dividend of kr3.00 Per Share

How Is NAXS' (STO:NAXS) CEO Compensated?

New 90-day high: kr54.80

New 90-day high: kr52.80

NAXS AB (publ) (STO:NAXS) Investors Should Think About This Before Buying It For Its Dividend

NAXS AB (publ) to Report Fiscal Year 2021 Results on Jan 27, 2022

New 90-day high: kr50.40

New 90-day high: kr49.60

Shareholders Of NAXS (STO:NAXS) Have Received 9.9% On Their Investment

New 90-day low: kr45.40

NAXS Nordic Access Buyout Fund AB to Report Nine Months, 2010 Results on 10/28/2010

New 90-day low: kr45.60

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven